Keyphrases
Acute Myeloid Leukemia
100%
Therapy Resistance
100%
Multiple Myeloma
100%
Macrophages
100%
Degrader
50%
Myeloma Cells
50%
Proteolysis Targeting chimera (PROTAC)
33%
Michigan
16%
Preclinical Efficacy
16%
Primary Cells
16%
Highly Effective
16%
University of Michigan
16%
Small Molecule Inhibitors
16%
Clinical Application
16%
STAT3 Inhibitor
16%
Protein Level
16%
Acute Myeloid Lymphoma
16%
Cancer Resistance
16%
Innovative University
16%
Phosphorylated STAT3
16%
Effective Compounds
16%
STAT3 Protein
16%
Therapeutic Innovation
16%
Highly Selective
16%
Clinical Applicability
16%
Therapeutic Potential
16%
Clinical Parameters
16%
Killing Effect
16%
Immune Cells
16%
STAT3 Activation
16%
Anticancer Drugs
16%
STAT Proteins
16%
Murine Model
16%
Multiple Myeloma Patients
16%
Medicine and Dentistry
Multiple Myeloma
100%
Macrophage
100%
Therapy Resistance
100%
Acute Myeloid Leukemia
100%
Myeloma Cell
33%
Protein Degradation
33%
STAT3 Protein
16%
Multiple Myeloma Cell Line
16%
STAT Protein
16%
Malignant Neoplasm
16%
Immunocompetent Cell
16%
Drug Resistance
16%
Anticarcinogen
16%
Immunology and Microbiology
Multiple Myeloma
100%
Macrophage
100%
Myeloid
100%
STAT3
100%
Myeloma Cell
18%
Protein Degradation
18%
Multiple Myeloma Cell Line
9%
STAT Protein
9%
Drug Resistance
9%
Immunocompetent Cell
9%